Article (Scientific journals)
Reduction comparable des nouveaux cas de diabete de type 2 sous sartan et sous inhibiteur de l'enzyme de conversion de l'angiotensine: comparaison des meta-analyses des essais prospectifs randomises.
Scheen, André
2005In Revue Médicale de Liège, 60 (5-6), p. 424-8
Peer reviewed
 

Files


Full Text
20050506_29.pdf
Publisher postprint (568.64 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Benzimidazoles/therapeutic use; Benzoates/therapeutic use; Diabetes Mellitus, Type 2/prevention & control; Heart Failure/complications/drug therapy; Humans; Hypertension/complications/drug therapy; Randomized Controlled Trials as Topic; Receptors, Angiotensin/physiology
Abstract :
[en] This paper aims at comparing two meta-analyses of clinical trials having investigated the effect of the inhibition of the renin-angiotensin system either with an angiotensin converting enzyme inhibitor (ACEI) or with a selective angiotensin receptor blocker (ARB) on the incidence of new cases of type 2 diabetes mellitus in subjects with arterial hypertension or with congestive heart failure. The protection appears similar with ACEIs in six trials in a total of 24.623 patients (hazard ratio: 0.77; CI 95% 0.72-0.81; p < 0.00001 and with ARBs in five trials in a total of 14.344 patients (hazard ratio: 0.79; CI 95% 0.73-0.85; p < 0.00001). It is consistent whatever the comparator, a thiazide diuretic agent, a beta-blocker, a dihydropyridine calcium channel blocker or a placebo. The large ongoing ONTARGET controlled study will allow a direct comparison between an ACEI, ramipril, and an ARB, telmisartan, and will also investigate the potential benefit of a combined treatment with both drugs. The inhibition of the renin-angiotensin system should be considered among pharmacological strategies of prevention of type 2 diabetes mellitus.
Disciplines :
Pharmacy, pharmacology & toxicology
Endocrinology, metabolism & nutrition
Author, co-author :
Scheen, André  ;  Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Language :
French
Title :
Reduction comparable des nouveaux cas de diabete de type 2 sous sartan et sous inhibiteur de l'enzyme de conversion de l'angiotensine: comparaison des meta-analyses des essais prospectifs randomises.
Alternative titles :
[en] Similar reduction in new cases of type 2 diabetes with angiotensin receptor blocker and ACE inhibitor: comparison of meta-analyses of prospective randomised trials
Publication date :
2005
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Special issue title :
Le diabète sucré dans tous ses états
Volume :
60
Issue :
5-6
Pages :
424-8
Peer reviewed :
Peer reviewed
Additional URL :
Available on ORBi :
since 06 April 2009

Statistics


Number of views
301 (0 by ULiège)
Number of downloads
267 (0 by ULiège)

Scopus citations®
 
10
Scopus citations®
without self-citations
3

Bibliography


Similar publications



Contact ORBi